Twin Capital Management Inc Bristol Myers Squibb CO Transaction History
Twin Capital Management Inc
- $776 Million
- Q3 2025
A detailed history of Twin Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Twin Capital Management Inc holds 79,124 shares of BMY stock, worth $3.7 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
79,124
Previous 109,439
27.7%
Holding current value
$3.7 Million
Previous $5.07 Million
29.56%
% of portfolio
0.46%
Previous 0.55%
Shares
34 transactions
Others Institutions Holding BMY
# of Institutions
2,682Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...